CLINICAL TRIALS PROFILE FOR AZASAN
✉ Email this page to a colleague
All Clinical Trials for AZASAN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00774852 ↗ | Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis | Completed | Immune Tolerance Network (ITN) | Phase 2 | 2008-11-01 | This study is for individuals with lupus who have developed complications in their kidneys, or lupus nephritis. The study will determine whether adding the experimental medication abatacept to standard cyclophosphamide therapy is more effective in improving lupus nephritis than standard cyclophosphamide therapy by itself. |
NCT00774852 ↗ | Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | 2008-11-01 | This study is for individuals with lupus who have developed complications in their kidneys, or lupus nephritis. The study will determine whether adding the experimental medication abatacept to standard cyclophosphamide therapy is more effective in improving lupus nephritis than standard cyclophosphamide therapy by itself. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AZASAN
Condition Name
Clinical Trial Locations for AZASAN
Trials by Country
Clinical Trial Progress for AZASAN
Clinical Trial Phase
Clinical Trial Sponsors for AZASAN
Sponsor Name